ASCO Tumor Boards: Ovarian

Product ID : ATB1806
Price: $15.00
You will receive a link to your product from within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend



The term “ovarian cancer”' is often used to describe cancers that begin in the cells in the ovary, fallopian tube, or peritoneum. The cancers are closely related and are treated the same way. It is the seventh most common cancer among women, and it is the fifth leading cause of cancer deaths among women worldwide. It is difficult to detect early since its symptoms can mimic other pelvic diseases, and the ovaries are not easily accessible for inspection or testing. This is a case-based activity that includes a discussion of a 45-year-old woman who was referred by her primary care physician to the medical oncologist after persistent abdominal bloating and gas pains did not abate after recommendation of dietary restrictions. Patient is para2/gravida2 with first menses at age 10 and last menses at age 43. Surgical history is notable for cholecystectomy at age 35. Family history is notable for hypertension and diabetes. On physical exam patient presented with no abdominal tenderness or guarding.

At the end of this course, learners should be able to:

  • Propose initial treatment course and follow-up for a patient with early-stage ovarian cancer.
  • Recognize how the platinum-free interval impacts choice of chemotherapy in recurrent ovarian cancer.
  • Describe the options for maintenance treatment in platinum-sensitive, recurrent ovarian cancer.
  • Consider differences in toxicities and dosing schedule preference when selecting PARP inhibitor for an individual patient.

Earn 1.5 AMA PRA Category 1 Credits™, CE, CNE, CPE, and MOC Points.

IMPORTANT NOTE: This course expires on November 14, 2020. Participants must complete all necessary course components by this date.

Purchase the 2018 ASCO Tumor Boards Bundle and SAVE $25 to access to all six 2018 ASCO Tumor Boards.